137 related articles for article (PubMed ID: 21176228)
1. Cost comparison of microscopy vs. empiric treatment for malaria in Southwestern Nigeria: a prospective study.
Parikh R; Amole I; Tarpley M; Gbadero D; Davidson M; Vermund SH
Malar J; 2010 Dec; 9():371. PubMed ID: 21176228
[TBL] [Abstract][Full Text] [Related]
2. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
4. Consequences of restricting antimalarial drugs to rapid diagnostic test-positive febrile children in south-west Nigeria.
Falade CO; Orimadegun AE; Michael OS; Dada-Adegbola HO; Ogunkunle OO; Badejo JA; Funwei RI; Ajayi IO; Jegede AS; Ojurongbe OD; Ssekitooleko J; Baba E; Hamade P; Webster J; Chandramohan D
Trop Med Int Health; 2019 Nov; 24(11):1291-1300. PubMed ID: 31465633
[TBL] [Abstract][Full Text] [Related]
5. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours).
Ayede IA; Falade AG; Sowunmi A; Jansen FH
Malar J; 2010 Dec; 9():378. PubMed ID: 21194422
[TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
7. Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso.
Bisoffi Z; Sirima SB; Meheus F; Lodesani C; Gobbi F; Angheben A; Tinto H; Neya B; Van den Ende K; Romeo A; Van den Ende J
Malar J; 2011 Aug; 10():226. PubMed ID: 21816087
[TBL] [Abstract][Full Text] [Related]
8. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
9. Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.
Bisoffi Z; Tinto H; Sirima BS; Gobbi F; Angheben A; Buonfrate D; Van den Ende J
PLoS One; 2013; 8(3):e58019. PubMed ID: 23472129
[TBL] [Abstract][Full Text] [Related]
10. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
11. The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Zurovac D; Larson BA; Akhwale W; Snow RW
Trop Med Int Health; 2006 Aug; 11(8):1185-94. PubMed ID: 16903882
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children.
Njama-Meya D; Clark TD; Nzarubara B; Staedke S; Kamya MR; Dorsey G
Malar J; 2007 Jan; 6():7. PubMed ID: 17239256
[TBL] [Abstract][Full Text] [Related]
13. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
Ladner J; Davis B; Audureau E; Saba J
Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT.
Uzochukwu BS; Obikeze EN; Onwujekwe OE; Onoka CA; Griffiths UK
Malar J; 2009 Nov; 8():265. PubMed ID: 19930666
[TBL] [Abstract][Full Text] [Related]
15. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
16. The benefits or otherwise of managing malaria cases with or without laboratory diagnosis: the experience in a district hospital in Ghana.
Osei-Kwakye K; Asante KP; Mahama E; Apanga S; Owusu R; Kwara E; Adjei G; Abokyi L; Yeetey E; Dosoo DK; Punguyire D; Owusu-Agyei S
PLoS One; 2013; 8(3):e58107. PubMed ID: 23505457
[TBL] [Abstract][Full Text] [Related]
17. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
[TBL] [Abstract][Full Text] [Related]
18. Malaria Surveillance - United States, 2016.
Mace KE; Arguin PM; Lucchi NW; Tan KR
MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
[TBL] [Abstract][Full Text] [Related]
19. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
[TBL] [Abstract][Full Text] [Related]
20. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
